Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Snyder Lab, |
RCV000678490 | SCV000804198 | pathogenic | Intellectual disability; Periodic paralysis; Neurodevelopmental delay | 2018-08-27 | criteria provided, single submitter | case-control | |
Kariminejad - |
RCV001814074 | SCV001755529 | likely pathogenic | Abnormality of the nervous system | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001850283 | SCV002178644 | uncertain significance | Developmental and epileptic encephalopathy, 1; Autosomal dominant nonsyndromic hearing loss 65; Caused by mutation in the TBC1 domain family, member 24 | 2022-08-16 | criteria provided, single submitter | clinical testing | The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects TBC1D24 function (PMID: 27281533, 30335140). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TBC1D24 protein function. ClinVar contains an entry for this variant (Variation ID: 183157). This missense change has been observed in individual(s) with clinical features of autosomal recessive TBC1D24-related conditions (PMID: 25401298). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 360 of the TBC1D24 protein (p.Arg360Leu). |
Institute of Human Genetics Munich, |
RCV002468571 | SCV002764926 | pathogenic | Developmental and epileptic encephalopathy, 16 | 2021-06-08 | criteria provided, single submitter | clinical testing | |
Division of Medical Genetics; Sainte- |
RCV000192071 | SCV000211974 | pathogenic | Epilepsy, progressive myoclonic, 1B | 2014-12-22 | no assertion criteria provided | literature only |